China Universal Asset Management Co., Ltd.
Position in CRVS — Corvus Pharmaceuticals, Inc.
CIK 1906594
SHANGHAI, F4
Position in CRVS
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$319,462
-$77,815 QoQ
Shares Held
21,383
-21.3% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#112
of 172 holders
Holding Since
Sep 2022
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026China Universal Asset Management Co., Ltd. holds $180,189,557 across 240 Biotechnology names. CRVS ranks #99 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
48,265 | $23,974,673 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
19,498 | $12,157,782 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
25,269 | $7,606,727 | |
| 4 | RPRX |
Royalty Pharma plc
|
120,547 | $6,759,070 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
33,835 | $6,336,618 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
76,302 | $6,049,985 | |
| 7 | MRNA |
Moderna, Inc.
|
63,149 | $4,422,324 | |
| 8 | ARGX |
Argenx SE
|
4,642 | $4,306,708 |
All Filings in CRVS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $319,462 | 21,383 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $397,277 | 27,155 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $139,901 | 18,169 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $96,259 | 13,061 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $61,952 | 15,488 | Shares | Sole | 2025-08-28 | |
| 2025-03-31 | $40,987 | 12,889 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $72,893 | 13,625 | Shares | Sole | 2025-01-24 | |
| 2022-09-30 | $357 | 436 | Shares | Sole | 2022-10-21 | |
| No filing history on record for this holder in this stock. | ||||||